flagyl filmuhúðuð tafla 400 mg
sanofi-aventis norge as - metronidazolum inn - filmuhúðuð tafla - 400 mg
flagyl leggangastíll 500 mg
sanofi-aventis norge as - metronidazolum inn - leggangastíll - 500 mg
holoxan innrennslisstofn, lausn 500 mg
baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 500 mg
holoxan innrennslisstofn, lausn 2000 mg
baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 2000 mg
holoxan innrennslisstofn, lausn 1000 mg
baxter medical ab* - ifosfamidum inn - innrennslisstofn, lausn - 1000 mg
metronidazol actavis filmuhúðuð tafla 500 mg
actavis group ptc ehf. - metronidazolum inn - filmuhúðuð tafla - 500 mg
metronidazol actavis filmuhúðuð tafla 250 mg
actavis group ptc ehf. - metronidazolum inn - filmuhúðuð tafla - 250 mg
risolid filmuhúðuð tafla 25 mg
teva b.v.* - chlordiazepoxidum inn - filmuhúðuð tafla - 25 mg
risolid filmuhúðuð tafla 10 mg
teva b.v.* - chlordiazepoxidum inn - filmuhúðuð tafla - 10 mg
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formóteróli fúmarat tvíhýdrat, Þannig brómíð - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.